P10, INC. PX 深 沪
已收盘 02-06 16:00:00 美东时间
10.20
+0.340
+3.45%
华盛通- 最 高10.21
- 今 开10.13
- 成交量 46.75万股
- 最 低 10.025
- 昨 收 9.86
- 总市值 11.22亿
- 52周最高 13.3225
- 市盈率 静 65.68
- 换手率 0.42%
- 52周最低 8.6425
- 委 比 0.00%
- 总股本 1.10亿
- 历史最高 14.7945
- 量 比 0.63
- 振 幅 1.88%
- 历史最低 6.8275
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stellus Capital Management to Become Part of Alternative Asset Manager P10
Transaction to provide complementary resources, expertise, and relationships to enhance Stellus' existing platform Stellus investment processes, strategy, and operations to remain unchanged ...
02-05 20:32
P10 Announces Upcoming Name Change
Ridgepost Capital,Inc. Name Change and Symbol Update Ridgepost Capital,Inc.（前P10,Inc.，NYSE:PX）宣布自2026年2月11日起正式更名为Ridgepost Capital,Inc.，股票代码同步变更为"RPC"。新名称象征着公司在中端和下中端市场的整合平台定位，致力于为股东提供多元化的投资策略组合，包括私人股本、私人信贷和风险投资。公司目前管理资产规模超过400亿美元，拥有全球投资者基础，旨在实现风险调整后的强劲回报。
01-12 12:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
JP Morgan Maintains Overweight on P10, Raises Price Target to $15.5
JP Morgan analyst Kenneth Worthington maintains P10 (NYSE:PX) with a Overweight and raises the price target from $15 to $15.5.
2025-11-08 04:05
RCP Advisors Closes Secondary Opportunity Fund V on $1.26 Billion, Exceeding Target Size
P10, Inc. and RCP Advisors announce the final close of RCP Secondary Opportunity Fund V, which reached $1.26 billion in commitments, surpassing its $1 billion target. The fund attracted diverse investors, including high net worth individuals, pension funds, and foundations. It will focus on investments in North American small buyout funds through secondary market purchases. Luke Sarsfield, CEO of P10, emphasized investor confidence in RCP's strat...
2025-10-01 20:30
P10 Holdings Enters Interest Rate Collar Agreement
P10 Holdings ( ($PX) ) has issued an update. On September 15, 2025, P10, Inc. e...
2025-09-19 18:29
P10 to Sponsor IPEM Paris 2025
P10, Inc. (NYSE: PX) is sponsoring and participating in IPEM Paris 2025, taking place September 24–26 at the Palais des Congrès in Paris. P10’s EVP, Global Head of Client Solutions, Sarita Narson Jairath, and representatives from five investment strategies will attend, including Bonaccord Capital Partners, Hark Capital, Qualitas Funds, RCP Advisors, and TrueBridge Capital Partners. The event is expected to host over 6,000 participants, including ...
2025-09-16 10:30
P10 to Participate in Barclays’ 23rd Annual Global Financial Services Conference
P10公司宣布，董事长兼首席执行官Luke Sarsfield和首席行政官Mark Hood将在9月8日的巴克莱全球金融服务会议上进行炉边谈话。讨论内容可在公司投资者关系页面观看，提供直播和回放链接，以及公司简介等信息。
2025-09-03 20:30
P10 Inc. Announces Dual Listing Of Its Class A Common Stock On NYSE Texas, Effective August 15, 2025
P10, Inc. (NYSE:PX), a leading private markets solutions provider, today announced a dual listing of its Class A common stock on NYSE Texas Inc. ("NYSE Texas"), the newly launched, fully electronic equities exchange
2025-08-14 18:46
